The muscarinic agonist xanomeline has antipsychotic-like activity in animals and in man

被引：0
|
作者：
Perry, KW [1 ]
Bymaster, FP [1 ]
Shannon, HE [1 ]
Rasmussen, K [1 ]
DeLapp, NW [1 ]
Zhang, W [1 ]
Ward, JS [1 ]
Calligaro, DO [1 ]
Fink-Jensen, A [1 ]
Sheardown, M [1 ]
Jeppesen, L [1 ]
Sauerberg, P [1 ]
机构：
[1] Lilly Res Labs, Neurosci Res Div, Indianapolis, IN 46285 USA
来源：
SCHIZOPHRENIA RESEARCH | 1999年 / 36卷 / 1-3期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：117 / 118
页数：2
相关论文
共 50 条
  • [41] The involvement of GABAB receptors in antipsychotic-like effects of positive allosteric modulator of muscarinic acetylcholine M4 receptors
    Cieslik, P.
    Wozniak, M.
    Pilc, A.
    Wieronska, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S965 - S966
  • [42] Atypical antipsychotic-like effects of the dopamine D3 receptor agonist, (+)-PD 128,907
    Witkin, J
    Gasior, M
    Acri, J
    Beekman, M
    Thurkauf, A
    Yuan, J
    DeBoer, P
    Wikström, H
    Dijkstra, D
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 347 (2-3) : R1 - R3
  • [43] Antipsychotic-like effects of the 5-HT2C selective agonist WAY-909 in rodents
    Rosenzweig-Lipson, S.
    Sabb, A.
    Brennan, J.
    Beyer, C.
    Comery, T.
    Piesla, M.
    Marquis, K.
    Ashby, C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 149 - 149
  • [44] L-stepholidine:: A D1 agonist D2 antagonist with an antipsychotic-like profile
    Mamo, DC
    Natesan, S
    VanderSpek, S
    Kapur, S
    [J]. SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 305 - 305
  • [45] Brexpiprazole II: Antipsychotic-Like and Procognitive Effects of a Novel Serotonin-Dopamine Activity Modulator
    Maeda, Kenji
    Lerdrup, Linda
    Sugino, Haruhiko
    Akazawa, Hitomi
    Amada, Naoki
    McQuade, Robert D.
    Stensbol, Tine Bryan
    Bundgaard, Christoffer
    Arnt, Jorn
    Kikuchi, Tetsuro
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (03): : 605 - 614
  • [46] Antipsychotic-like effect and cataleptogenic potential of the dopamine D2 receptor partial agonist 2-bromoterguride
    Brosda, J.
    Franke, R.
    Jantschak, F.
    Pertz, H. H.
    Fink, H.
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2013, 386 : S13 - S13
  • [47] A novel selective positive allosteric modulator of metabotropic glutamate receptor subtype 5 has in vivo activity and antipsychotic-like effects in rat behavioral models
    Kinney, GG
    O'Brien, JA
    Lemaire, W
    Burno, M
    Bickel, DJ
    Clements, MK
    Chen, TB
    Wisnoski, DD
    Lindsley, CW
    Tiller, PR
    Smith, S
    Jacobson, MA
    Sur, C
    Duggan, ME
    Pettibone, DJ
    Conn, PJ
    Williams, DL
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 313 (01): : 199 - 206
  • [48] Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice
    Zmudzka, Elzbieta
    Lustyk, Klaudia
    Gluch-Lutwin, Monika
    Wolak, Malgorzata
    Jaskowska, Jolanta
    Kolaczkowski, Marcin
    Sapa, Jacek
    Pytka, Karolina
    [J]. PHARMACEUTICALS, 2023, 16 (02)
  • [49] SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF ALKYL SUBSTITUTED ANALOGS OF THE FUNCTIONAL M(1) SELECTIVE MUSCARINIC RECEPTOR AGONIST XANOMELINE
    QUIMBY, SJ
    SHANNON, HE
    BYMASTER, FP
    SAUERBERG, P
    OLESEN, PH
    SHEARDOWN, MJ
    SUZDAK, PD
    MITCH, CH
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (18) : 2205 - 2210
  • [50] Brexpiprazole, a Novel Serotonin-Dopamine Activity Modulator: In Vivo Evaluation of its Antipsychotic-Like Profile
    Amada, Naoki
    Maeda, Kenji
    Akazawa, Hitomi
    Sugino, Haruhiko
    Stensbol, Tine B.
    Kikuchi, Tetsuro
    [J]. BIOLOGICAL PSYCHIATRY, 2014, 75 (09) : 132S - 132S
12345